Hazlett, Burt & Watson’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $817K | Buy |
11,829
+1,516
| +15% | +$105K | 0.33% | 70 |
|
|
2025
Q1 | $714K | Sell |
10,313
-148
| -1% | -$10.2K | 0.32% | 74 |
|
|
2024
Q4 | $904K | Buy |
10,461
+741
| +8% | +$64K | 0.4% | 61 |
|
|
2024
Q3 | $1.16M | Buy |
9,720
+12
| +0.1% | +$1.43K | 0.53% | 43 |
|
|
2024
Q2 | $1.39M | Buy |
9,708
+408
| +4% | +$58.4K | 0.72% | 30 |
|
|
2024
Q1 | $1.2M | Buy |
9,300
+266
| +3% | +$34.2K | 0.72% | 25 |
|
|
2023
Q4 | $938K | Buy |
9,034
+3,494
| +63% | +$363K | 0.63% | 28 |
|
|
2023
Q3 | $503K | Buy |
5,540
+86
| +2% | +$7.81K | 0.37% | 52 |
|
|
2023
Q2 | $442K | Buy |
5,454
+16
| +0.3% | +$1.3K | 0.33% | 61 |
|
|
2023
Q1 | $434K | Hold |
5,438
| – | – | 0.35% | 57 |
|
|
2022
Q4 | $368K | Hold |
5,438
| – | – | 0.32% | 65 |
|
|
2022
Q3 | $270K | Hold |
5,438
| – | – | 0.26% | 81 |
|
|
2022
Q2 | $304K | Sell |
5,438
-350
| -6% | -$19.6K | 0.28% | 75 |
|
|
2022
Q1 | $320K | Buy |
+5,788
| New | +$320K | 0.25% | 84 |
|